CNO Financial (CNO)


Market Price (8/3/2026): $55.075 | Market Cap: $5.2 BilSector: Financials | Industry: Life & Health Insurance

CNO Financial (CNO)


Market Price (8/3/2026): $55.075
Market Cap: $5.2 Bil
Sector: Financials
Industry: Life & Health Insurance

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.0%, FCF Yield is 13%

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -93%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%

Low stock price volatility
Vol 12M is 22%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more.

Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%

Key risks
CNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.0%, FCF Yield is 13%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -93%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%
3 Low stock price volatility
Vol 12M is 22%
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more.
5 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
6 Key risks
CNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities.

CNO in ETFs

Weight = CNO's share of each fund

ITOT0.01%
IWM0.16%
IJH0.14%
VIG0.02%
VYM0.02%
VB0.05%
AVUV0.56%
IWN0.33%
+14 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/1/2026

CNO Financial (CNO) stock has gained about 25% since 4/30/2026 because of the following key factors:

1. CNO Financial Group's strong financial performance in fiscal Q2 2026 significantly surpassed analyst expectations, leading to an upward revision of its full-year guidance. The company reported operating earnings per share (EPS) of $1.26, substantially beating the consensus estimate of $0.97 by $0.29 (a 29.9% beat). Quarterly revenue also exceeded forecasts, rising 11.6% year-over-year to $1.29 billion against estimates of $999.45 million. Following these results, CNO raised its full-year 2026 operating EPS guidance by 8% at the midpoint.

2. The company demonstrated consistent and broad-based sales growth across its insurance businesses, extending its track record of strong operational momentum. CNO Financial Group achieved its 16th consecutive quarter of sales growth, with total new annualized premiums (NAP) increasing 7% in fiscal Q2 2026. Notably, Medicare Supplement sales surged by 52%, and Worksite life and health premiums grew by 29%. This sales momentum was further supported by the 14th consecutive quarter of producing agent count growth.

Show more
Updated on 8/1/2026

CNO Financial (CNO) stock has gained about 25% since 4/30/2026 because of the following key factors:

1. CNO Financial Group's strong financial performance in fiscal Q2 2026 significantly surpassed analyst expectations, leading to an upward revision of its full-year guidance. The company reported operating earnings per share (EPS) of $1.26, substantially beating the consensus estimate of $0.97 by $0.29 (a 29.9% beat). Quarterly revenue also exceeded forecasts, rising 11.6% year-over-year to $1.29 billion against estimates of $999.45 million. Following these results, CNO raised its full-year 2026 operating EPS guidance by 8% at the midpoint.

2. The company demonstrated consistent and broad-based sales growth across its insurance businesses, extending its track record of strong operational momentum. CNO Financial Group achieved its 16th consecutive quarter of sales growth, with total new annualized premiums (NAP) increasing 7% in fiscal Q2 2026. Notably, Medicare Supplement sales surged by 52%, and Worksite life and health premiums grew by 29%. This sales momentum was further supported by the 14th consecutive quarter of producing agent count growth.

3. Disciplined capital deployment, including substantial share repurchases, enhanced shareholder value and contributed to the stock's positive trend. In fiscal Q2 2026, CNO returned $77 million to shareholders. This included $60 million allocated to common stock repurchases, resulting in the repurchase of 1.3 million common shares at an average cost of $46.57 per share. These buybacks led to a 5% reduction in weighted average diluted shares outstanding. Additionally, the company paid $16.8 million in common stock dividends during the quarter.

4. Improved net investment income and favorable underwriting experience bolstered profitability. CNO Financial Group reported an 8% year-over-year increase in net investment income, marking its 11th consecutive quarter of growth in this area. The new money rate on investments reached 6.16%, maintaining a rate above 6% for the 14th consecutive quarter. Favorable underwriting across nearly all products also contributed to higher insurance product margins, supporting the strong earnings performance.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 24.4% change in CNO stock from 4/30/2026 to 8/2/2026 was primarily driven by a 14.9% change in the company's P/E Multiple.
(LTM values as of)43020268022026Change
Stock Price ($)44.2955.0924.4%
Change Contribution By: 
Total Revenues ($ Mil)4,4874,5130.6%
Net Income Margin (%)5.1%5.4%6.5%
P/E Multiple18.421.114.9%
Shares Outstanding (Mil)95941.1%
Cumulative Contribution24.4%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/2/2026
ReturnCorrelation
CNO24.4% 
Market (SPY)3.9%-9.4%
Sector (XLF)9.2%52.2%

Fundamental Drivers

The 32.0% change in CNO stock from 1/31/2026 to 8/2/2026 was primarily driven by a 67.2% change in the company's P/E Multiple.
(LTM values as of)13120268022026Change
Stock Price ($)41.7255.0932.0%
Change Contribution By: 
Total Revenues ($ Mil)4,4424,5131.6%
Net Income Margin (%)7.2%5.4%-24.3%
P/E Multiple12.621.167.2%
Shares Outstanding (Mil)97942.7%
Cumulative Contribution32.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/2/2026
ReturnCorrelation
CNO32.0% 
Market (SPY)8.3%26.4%
Sector (XLF)7.1%66.9%

Fundamental Drivers

The 52.0% change in CNO stock from 7/31/2025 to 8/2/2026 was primarily driven by a 90.8% change in the company's P/E Multiple.
(LTM values as of)73120258022026Change
Stock Price ($)36.2455.0952.0%
Change Contribution By: 
Total Revenues ($ Mil)4,2974,5135.0%
Net Income Margin (%)7.7%5.4%-29.2%
P/E Multiple11.121.190.8%
Shares Outstanding (Mil)101947.1%
Cumulative Contribution52.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/2/2026
ReturnCorrelation
CNO52.0% 
Market (SPY)19.2%29.8%
Sector (XLF)10.0%67.3%

Fundamental Drivers

The 126.9% change in CNO stock from 7/31/2023 to 8/2/2026 was primarily driven by a 238.8% change in the company's P/E Multiple.
(LTM values as of)73120238022026Change
Stock Price ($)24.2855.09126.9%
Change Contribution By: 
Total Revenues ($ Mil)3,7404,51320.7%
Net Income Margin (%)11.9%5.4%-54.4%
P/E Multiple6.221.1238.8%
Shares Outstanding (Mil)1159421.8%
Cumulative Contribution126.9%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/2/2026
ReturnCorrelation
CNO126.9% 
Market (SPY)68.9%51.8%
Sector (XLF)68.4%73.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
CNO Return10%-2%25%36%16%27%170%
Peers Return8%22%16%32%1%12%128%
S&P 500 Return27%-19%24%23%16%9%98%

Monthly Win Rates [3]
CNO Win Rate58%42%58%50%83%57% 
Peers Win Rate62%52%60%65%53%60% 
S&P 500 Win Rate75%42%67%75%67%43% 

Max Drawdowns [4]
CNO Max Drawdown-20%-35%-21%-11%-16%-11% 
Peers Max Drawdown-23%-23%-22%-23%-22%-16% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: GL, AFL, UNM, PRI, KMPR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/31/2026 (YTD)

How Low Can It Go

EventCNOS&P 500
2025 US Tariff Shock
  % Loss-12.6%-18.8%
  % Gain to Breakeven14.4%23.1%
  Time to Breakeven210 days79 days
2023 SVB Regional Banking Crisis
  % Loss-21.1%-6.7%
  % Gain to Breakeven26.7%7.1%
  Time to Breakeven201 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-30.6%-24.5%
  % Gain to Breakeven44.2%32.4%
  Time to Breakeven176 days427 days
2020 COVID-19 Crash
  % Loss-53.5%-33.7%
  % Gain to Breakeven115.0%50.9%
  Time to Breakeven214 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-34.3%-19.2%
  % Gain to Breakeven52.2%23.8%
  Time to Breakeven686 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-17.2%-12.2%
  % Gain to Breakeven20.7%13.9%
  Time to Breakeven21 days62 days

Compare to GL, AFL, UNM, PRI, KMPR

In The Past

CNO Financial's stock fell -12.6% during the 2025 US Tariff Shock. Such a loss loss requires a 14.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventCNOS&P 500
2023 SVB Regional Banking Crisis
  % Loss-21.1%-6.7%
  % Gain to Breakeven26.7%7.1%
  Time to Breakeven201 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-30.6%-24.5%
  % Gain to Breakeven44.2%32.4%
  Time to Breakeven176 days427 days
2020 COVID-19 Crash
  % Loss-53.5%-33.7%
  % Gain to Breakeven115.0%50.9%
  Time to Breakeven214 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-34.3%-19.2%
  % Gain to Breakeven52.2%23.8%
  Time to Breakeven686 days105 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-36.2%-17.9%
  % Gain to Breakeven56.8%21.8%
  Time to Breakeven165 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-24.6%-15.4%
  % Gain to Breakeven32.6%18.2%
  Time to Breakeven153 days125 days
2008-2009 Global Financial Crisis
  % Loss-97.9%-53.4%
  % Gain to Breakeven4734.6%114.4%
  Time to Breakeven1546 days1085 days
Summer 2007 Credit Crunch
  % Loss-32.8%-8.6%
  % Gain to Breakeven48.9%9.5%
  Time to Breakeven2947 days47 days

Compare to GL, AFL, UNM, PRI, KMPR

In The Past

CNO Financial's stock fell -12.6% during the 2025 US Tariff Shock. Such a loss loss requires a 14.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About CNO Financial (CNO)

CNO Financial Group, Inc. (CNO) is an insurance holding company that develops, markets, and administers a diverse portfolio of insurance products across the United States. Its core business centers on providing financial protection and retirement solutions, primarily through health insurance, individual life insurance, and annuities. The company operates by serving individuals directly and engaging in worksite and group sales for businesses and associations.

CNO's product offerings include a variety of health insurance policies such as Medicare supplements, supplemental health, long-term care, and Medicare Advantage plans. In life insurance, it provides universal life, traditional whole life, graded benefit life, and term life products. Additionally, CNO offers a range of annuities, including fixed index, fixed interest, and single premium immediate annuities. The company primarily targets the senior and middle-income markets, delivering its products through its Bankers Life, Washington National, and Colonial Penn brands via agents, independent producers, and direct marketing channels.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe CNO Financial:

  • Imagine it as a company similar to **Aflac**, but for seniors and middle-income individuals, also offering life insurance and annuities in addition to supplemental health products.

  • Think of it as **Humana**, but also providing a full range of life insurance and annuities specifically for seniors and middle-income customers.

AI Analysis | Feedback

  • Health Insurance: Provides various health-related insurance policies, including Medicare supplement, supplemental health, long-term care, and Medicare Advantage plans.
  • Annuities: Offers a range of annuity products, such as fixed index, fixed interest, and single premium immediate annuities, to provide guaranteed income streams.
  • Life Insurance: Delivers individual life insurance policies, encompassing universal life, traditional life (whole, term), and other interest-sensitive products.

AI Analysis | Feedback

Major Customers of CNO Financial (CNO)

CNO Financial Group primarily sells its insurance and annuity products directly to individuals. Based on the company description, its major customer categories include:

  • Seniors and Retirees: The company extensively targets the senior market with products such as Medicare supplement, Medicare Advantage plans, supplemental health, and long-term care insurance, as well as annuities, specifically catering to retirees and older self-employed individuals.
  • Middle-Income Individuals: CNO focuses on individuals within the middle-income demographic for a range of its life insurance, health insurance, and annuity products.
  • Employees and Members of Businesses/Groups: Through its worksite and group sales channels, CNO provides products to employees of businesses, associations, and other membership groups, interacting with these customers at their places of employment.

AI Analysis | Feedback

null

AI Analysis | Feedback

Gary C. Bhojwani, Chief Executive Officer

Gary C. Bhojwani became Chief Executive Officer of CNO Financial Group on January 1, 2018, having previously served as President of the company from April 2016 through December 2017. Prior to joining CNO, Mr. Bhojwani held senior leadership positions at Allianz, including being a member of the Board of Management of Allianz SE and chairman of Allianz of America, Allianz Life Insurance Company, and Fireman's Fund Insurance Company from 2012 to 2015. He also served as Chief Executive Officer of Allianz Life Insurance Company of North America from 2007 through 2012 and as Chief Executive Officer of Lincoln General Insurance Company from 2002 to 2004. Notably, Mr. Bhojwani founded Avalon Risk Management in 1998, serving as its Chief Executive Officer until 2002, and also founded Gcb LLC in 2015, where he was CEO until 2016.

Paul H. McDonough, Chief Financial Officer

Paul H. McDonough was appointed Chief Financial Officer for CNO Financial Group in March 2019. He brings nearly 30 years of public company finance experience and 20 years in the insurance industry. Before joining CNO, he served as Executive Vice President and Chief Financial Officer for OneBeacon Insurance Group from 2005 to 2017. Mr. McDonough was also Chief Financial Officer at BJ's Wholesale Club in 2005 and held various treasury leadership roles at The St. Paul Companies (now Travelers). His earlier career included finance and strategic planning positions at Sears and Chevron, and he proudly served as an Officer in the U.S. Navy and Navy Reserve for six years.

Scott L. Goldberg, President, Consumer Division

Scott L. Goldberg serves as the President of the Consumer Division at CNO Financial Group. He previously held the position of President of Bankers Life and Casualty Company, a CNO Financial Group subsidiary.

Matthew J. Zimpfer, Executive Vice President and General Counsel

Matthew J. Zimpfer was appointed Executive Vice President and General Counsel of CNO Financial Group in June 2008. In addition, he currently serves as the President of CNO Bermuda Re, the company's Bermuda-based captive reinsurer. Mr. Zimpfer joined CNO in January 1998, taking on various legal roles including interim general counsel and vice president and deputy general counsel. His professional background prior to CNO includes being a managing partner at Zimpfer Klineman & Wright, in-house counsel at Progressive Insurance Company, and a law clerk and associate at White & Raub.

Eric R. Johnson, Chief Investment Officer and President, 40|86 Advisors, Inc.

Eric R. Johnson holds the titles of Chief Investment Officer at CNO Financial Group and President of 40|86 Advisors, Inc., a wholly-owned registered investment advisor subsidiary of CNO.

AI Analysis | Feedback

Here are the key risks to CNO Financial (CNO):

  1. Regulatory and Legal Challenges: CNO Financial operates in a highly regulated industry, and changes to regulations pose a significant risk to its business model. Potential shifts in fiduciary standards, state-level Medicare Advantage commission rules, or risk-based capital requirements could disrupt product distribution, increase compliance costs, and necessitate substantial adjustments to business practices. The company is subject to various legal and regulatory proceedings, which can lead to financial penalties, increased expenses, and reputational damage.

  2. Economic and Market Conditions, including Interest Rate Fluctuations: CNO's profitability is significantly influenced by broader economic factors, particularly interest rates and market volatility. Prolonged low interest rates can reduce the net spread between investment earnings and interest credited to products like annuities, impacting profitability. Conversely, periods of increasing interest rates may lead to higher policy loans, surrenders, and withdrawals as policyholders seek better returns elsewhere, potentially forcing CNO to sell invested assets at depressed prices and realize losses. General economic downturns, inflation, and market instability can also depress demand for life insurance, annuities, and other insurance products, while leading to higher lapses or surrenders.

  3. Intense Competition and Distribution Model Disruption: CNO faces substantial competition from companies that often have greater market share, higher ratings, and more extensive financial resources and distribution networks. This competitive pressure can affect pricing, distribution share, and the company's ability to attract and retain customers. Furthermore, CNO's business model heavily relies on its high-touch agent distribution, and any reclassification of products or limits on agent compensation could disrupt this core aspect of its operations and market position.

AI Analysis | Feedback

The proliferation of direct-to-consumer, AI-powered digital insurance platforms that offer simplified, personalized, and automated purchasing processes for health, life, and annuity products, potentially bypassing CNO's traditional agent networks and direct marketing channels by offering superior convenience and cost efficiency.

AI Analysis | Feedback

null

AI Analysis | Feedback

CNO Financial Group (CNO) is expected to drive future revenue growth over the next 2-3 years through several strategic initiatives:

  1. Consistent Sales Growth in Core Insurance Products: CNO Financial has demonstrated sustained sales momentum across its core insurance offerings, including life, health, and annuities, within its Consumer and Worksite Divisions. The company reported record total new annualized premiums, with double-digit increases in life, supplemental health, and annuities. This growth is underpinned by CNO's dedicated focus on the middle-income market.
  2. Expansion in the Senior Market and Medicare-related Products: CNO is strategically positioned to capitalize on the increasing demographic of Americans turning 65, driving demand for Medicare Supplement, Medicare Advantage/Part D, and long-term care alternatives. The company is actively scaling its Bankers Life distribution network into fast-growing Sun Belt and Midwest metropolitan areas to further penetrate this market.
  3. Growth in Worksite and Voluntary Benefits: The Worksite Division is a significant contributor to CNO's revenue growth, having achieved record sales and consistent new annualized premium growth. Management anticipates annual worksite sales growth of 12% to 15%, driven by the rising demand for voluntary benefits and the integration of comprehensive benefits communication and enrollment services for small-to-mid employers.
  4. Investment in Technology and Digital Transformation: CNO Financial is investing in technology to enhance its distribution and operational efficiency. This includes developing AI-driven agent tools, implementing end-to-end eApp adoption, and improving omnichannel enrollment platforms to boost agent productivity, refine targeting, and improve participation rates in worksite benefits. These digital advancements are expected to improve sales effectiveness and broaden customer reach.
  5. Product Innovation and Diversification: CNO is expanding its product portfolio to meet evolving consumer needs and market conditions. This includes widening its product strategy to offer supplemental health and fixed indexed annuities, particularly calibrated for higher interest rate environments. Additionally, the introduction of new simplified-issue life products designed for younger families aims to shorten issuance times and expand CNO's market presence beyond its traditional senior-focused lines.

AI Analysis | Feedback

<h3>Share Repurchases</h3> <ul> <li>CNO returned $386 million to shareholders in 2025, an 11% increase over 2024, through buybacks and dividends.</li> <li>The Board authorized an additional $500 million for share repurchases in February 2025, with approximately $240.3 million of remaining repurchase capacity as of December 31, 2024.</li> <li>As of December 31, 2025, CNO had authority to repurchase up to an additional $420.4 million of common stock.</li> </ul> <h3>Outbound Investments</h3> <ul> <li>CNO acquired a minority interest in Victory Park Capital (VPC) in September 2025 and committed a minimum of $600 million in capital to VPC's investment strategies.</li> <li>In April 2022, CNO acquired a strategic minority interest in Rialto Capital, a commercial real estate investment and asset management platform, and committed to invest in Rialto-managed vehicles.</li> <li>CNO acquired DirectPath, LLC, an employee benefits management services provider, in February 2021 for approximately $50 million.</li> </ul> <h3>Capital Expenditures</h3> <ul> <li>CNO Financial Group is engaged in a technology modernization initiative, with $75 million expected to be deployed in 2026.</li> <li>In 2025, approximately $20 million was deployed towards this technology modernization.</li> <li>The primary focus of these capital expenditures is on digital investment to enhance agent productivity, operational efficiency, reduce costs, and support growth initiatives like digital-first distribution and AI-driven agent tools.</li> </ul>

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Mkt Price55.09182.25127.4886.11319.9628.38106.80
Mkt Cap5.214.365.413.710.11.711.9
Rev LTM4,5136,07418,31013,2453,3604,6935,383
Op Inc LTM-------
FCF LTM6881,2302,934693834460764
FCF 3Y Avg6511,3152,8431,126782259954
CFO LTM6881,3852,934830861493845
CFO 3Y Avg6511,4082,8431,2618123061,037

Growth & Margins

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Rev Chg LTM5.0%4.0%6.8%3.3%6.4%0.3%4.5%
Rev Chg 3Y Avg6.6%6.6%-0.6%3.2%8.2%-4.4%4.9%
Rev Chg Q2.5%5.3%27.7%0.1%8.4%-7.6%3.9%
QoQ Delta Rev Chg LTM0.6%1.3%5.5%0.0%2.1%-1.9%0.9%
Op Inc Chg LTM-------
Op Inc Chg 3Y Avg-------
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM15.2%22.8%16.0%6.3%25.6%10.5%15.6%
CFO/Rev 3Y Avg14.9%24.2%15.5%9.8%26.1%6.5%15.2%
FCF/Rev LTM15.2%20.2%16.0%5.2%24.8%9.8%15.6%
FCF/Rev 3Y Avg14.9%22.6%15.5%8.8%25.1%5.6%15.2%

Valuation

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Mkt Cap5.214.365.413.710.11.711.9
P/S1.12.43.61.03.00.41.8
P/Op Inc-------
P/EBIT9.79.011.212.39.924.010.5
P/E21.112.214.119.613.139.816.8
P/CFO7.510.322.316.611.83.411.1
Total Yield6.0%8.8%8.9%7.3%9.0%7.2%8.1%
Dividend Yield1.3%0.6%1.8%2.2%1.4%4.7%1.6%
FCF Yield 3Y Avg17.1%13.1%5.1%9.3%8.9%12.1%10.7%
D/E0.80.20.10.30.20.60.2
Net D/E-0.9-1.1-1.0-2.4-0.00.3-0.9

Returns

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
1M Rtn5.1%1.2%5.5%-6.2%7.7%-1.6%3.1%
3M Rtn23.9%19.6%13.5%7.1%16.0%-16.0%14.8%
6M Rtn32.0%30.5%16.1%14.7%22.7%-26.5%19.4%
12M Rtn57.8%33.9%32.7%26.5%25.4%-51.0%29.6%
3Y Rtn135.1%64.0%76.4%84.7%54.1%-39.3%70.2%
1M Excs Rtn5.7%1.3%7.5%-5.3%9.6%0.3%3.5%
3M Excs Rtn20.5%14.4%8.8%3.9%10.3%-18.7%9.6%
6M Excs Rtn25.3%23.3%9.1%7.4%15.8%-33.4%12.4%
12M Excs Rtn37.6%12.5%14.4%6.3%6.5%-69.1%9.5%
3Y Excs Rtn64.1%0.0%22.8%27.5%-6.7%-101.8%11.4%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Health1,9631,9181,8911,9111,949
Life1,0731,0521,0271,001987
Annuity661600545503482
Investment income not allocated to product lines507450336258273
Fee revenue185190178169148
Change in market values of the underlying options supporting the fixed indexed annuity and life119254132-205220
Revenues related to earnings attributable to Variable interest entities (VIEs)2432714527
Fee revenue related to divested business7    
Amounts netted in expenses not allocated to product lines43373017
Investment gains (losses)-55-50-69-13519
Total4,4874,4504,1473,5774,122


Operating Income by Segment
$ Mil20152008
Bankers Life370172
Washington National112 
Colonial Penn625
Corporate operations-64 
Conseco Insurance Group 121
Corporate -65
Total423253


Net Income by Segment
$ Mil20152014201320112010
Bankers Life8859571,006766759
Washington National254276206190185
Colonial Penn4342404139
Corporate operations1115   
Corporate  401319
Other CNO Business  342344365
Total1,1931,2901,6341,3541,367


Assets by Segment
$ Mil20252024202320222021
Annuity13,69213,00612,00610,97113,289
Investments not allocated to product lines10,88010,5988,7128,8577,093
Health9,3679,1179,5129,02010,559
Life4,3314,1954,1543,7844,686
Assets of our other non-life companies359680399293384
Assets of our non-life companies included in the fee income segment161258244208194
Total38,79137,85335,02733,13336,204


Price Behavior

Price Behavior
Market Price$55.09 
Market Cap ($ Bil)5.2 
First Trading Date09/10/2003 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$50.76$43.98
DMA Trendupup
Distance from DMA8.5%25.3%
 3M1YR
Volatility18.9%21.4%
Downside Capture-66.0911.37
Upside Capture40.2861.49
Correlation (SPY)-12.0%29.6%
CNO Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta0.51-0.20-0.130.410.490.87
Up Beta0.55-0.170.040.750.890.98
Down Beta0.91-0.46-0.260.230.440.99
Up Capture97%50%39%58%51%61%
Bmk +ve Days11223567138427
Stock +ve Days14283875148412
Down Capture-24%-77%-77%6%18%86%
Bmk -ve Days11212859114326
Stock -ve Days8142450101333

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO55.6%21.7%1.94-
Sector ETF (XLF)9.4%14.8%0.3966.5%
Equity (SPY)18.8%12.9%1.0729.3%
Gold (GLD)23.6%28.1%0.74-9.3%
Commodities (DBC)30.2%19.7%1.22-17.6%
Real Estate (VNQ)13.7%13.9%0.6934.5%
Bitcoin (BTCUSD)-46.8%43.0%-1.3419.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO22.0%28.2%0.71-
Sector ETF (XLF)11.3%18.4%0.4773.8%
Equity (SPY)12.6%17.1%0.5655.8%
Gold (GLD)17.1%18.5%0.75-0.2%
Commodities (DBC)9.0%19.5%0.3511.8%
Real Estate (VNQ)2.5%18.9%0.0348.4%
Bitcoin (BTCUSD)13.4%53.3%0.4319.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO14.3%34.1%0.48-
Sector ETF (XLF)13.6%22.0%0.5679.8%
Equity (SPY)15.0%17.9%0.7165.4%
Gold (GLD)11.3%16.1%0.57-1.4%
Commodities (DBC)7.3%18.0%0.3223.4%
Real Estate (VNQ)4.9%20.7%0.2057.0%
Bitcoin (BTCUSD)57.6%66.2%0.9815.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity1.7 Mil
Short Interest: % Change Since 6302026-27.4%
Average Daily Volume0.8 Mil
Days-to-Cover Short Interest2.2 days
Basic Shares Quantity94.1 Mil
Short % of Basic Shares1.8%

Earnings Returns History

Updated 8/3/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/30/20263.0%  
4/30/20260.4%3.3%3.4%
2/5/20265.5%2.1%-2.7%
11/3/20254.3%3.3%1.8%
7/28/2025-1.6%-4.6%4.4%
4/28/2025-4.8%-6.4%-6.2%
2/6/20252.6%3.7%-3.1%
10/31/20244.4%12.0%14.4%
...
SUMMARY STATS   
# Positive151314
# Negative101110
Median Positive2.8%3.0%6.3%
Median Negative-3.1%-2.8%-6.4%
Max Positive10.7%12.1%20.5%
Max Negative-11.0%-12.6%-14.7%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/30/20263.0%  
4/30/20260.4%3.3%3.4%
2/5/20265.5%2.1%-2.7%
11/3/20254.3%3.3%1.8%
7/28/2025-1.6%-4.6%4.4%
4/28/2025-4.8%-6.4%-6.2%
2/6/20252.6%3.7%-3.1%
10/31/20244.4%12.0%14.4%
7/29/202410.7%2.1%9.2%
4/29/2024-2.1%3.0%2.7%
2/6/20242.8%-0.3%0.5%
11/6/20231.9%0.5%10.1%
7/31/2023-5.3%-2.2%-9.2%
5/1/2023-0.4%-4.7%-4.6%
2/7/20230.8%0.5%-6.5%
10/31/20220.1%-1.4%6.4%
8/1/2022-4.0%-1.3%-1.4%
5/2/2022-11.0%-12.6%-14.7%
2/8/2022-1.7%-3.8%-10.1%
10/27/2021-4.1%0.0%-9.2%
7/28/20210.5%-2.3%6.2%
4/28/20210.9%1.0%3.0%
2/9/2021-2.0%-2.8%11.6%
11/2/20206.5%12.1%20.5%
8/4/20206.3%10.9%13.4%
SUMMARY STATS   
# Positive151314
# Negative101110
Median Positive2.8%3.0%6.3%
Median Negative-3.1%-2.8%-6.4%
Max Positive10.7%12.1%20.5%
Max Negative-11.0%-12.6%-14.7%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/07/202610-Q
12/31/202502/24/202610-K
09/30/202511/06/202510-Q
06/30/202508/06/202510-Q
03/31/202505/07/202510-Q
12/31/202402/26/202510-K
09/30/202411/07/202410-Q
06/30/202408/09/202410-Q
03/31/202405/06/202410-Q
12/31/202302/23/202410-K
09/30/202311/08/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202202/24/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/07/202610-Q
12/31/202502/24/202610-K
09/30/202511/06/202510-Q
06/30/202508/06/202510-Q
03/31/202505/07/202510-Q
12/31/202402/26/202510-K
09/30/202411/07/202410-Q
06/30/202408/09/202410-Q
03/31/202405/06/202410-Q
12/31/202302/23/202410-K
09/30/202311/08/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202202/24/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q
03/31/202205/06/202210-Q
12/31/202102/24/202210-K
09/30/202111/04/202110-Q
06/30/202108/06/202110-Q
03/31/202105/07/202110-Q
12/31/202002/24/202110-K
09/30/202011/06/202010-Q
06/30/202008/07/202010-Q
03/31/202005/11/202010-Q
12/31/201902/25/202010-K
09/30/201911/06/201910-Q
06/30/201908/06/201910-Q

Recent Forward Guidance

Updated 7/31/2026

Latest: Q2 2026 Earnings Reported 7/30/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Operating EPS Growth 8.0%   Raised

Prior: Q1 2026 Earnings Reported 4/30/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Share Repurchases 360.40 Mil    

Q4 2025 Earnings Reported 2/5/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2027 ROE Target     AffirmedGuidance: 0.02 for 2027

Q3 2025 Earnings Reported 11/3/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Annual Fee Revenue Reduction 30.00 Mil    
2026 Annual Pre-tax Income Increase 20.00 Mil    
2027 ROE Improvement Target 0.02    

Insider Activity

Updated 7/1/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Tarasi, Rocco F IiiChief Marketing OfficerDirectSell701202651.311,89197,0273,966,263Form
2Bhojwani, Gary CChief Executive OfficerDirectSell701202651.4886,0484,429,4578,970,515Form
3Tarasi, Rocco F IiiChief Marketing OfficerDirectSell611202650.005,750287,5003,959,550Form
4Tarasi, Rocco F IiiChief Marketing OfficerDirectSell611202649.003,308162,0923,880,359Form
5Tarasi, Rocco F IiiChief Marketing OfficerDirectSell604202647.004,808225,9763,877,453Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Tarasi, Rocco F IiiChief Marketing OfficerDirectSell701202651.311,89197,0273,966,263Form
2Bhojwani, Gary CChief Executive OfficerDirectSell701202651.4886,0484,429,4578,970,515Form
3Tarasi, Rocco F IiiChief Marketing OfficerDirectSell611202650.005,750287,5003,959,550Form
4Tarasi, Rocco F IiiChief Marketing OfficerDirectSell611202649.003,308162,0923,880,359Form
5Tarasi, Rocco F IiiChief Marketing OfficerDirectSell604202647.004,808225,9763,877,453Form
6Goldberg, Scott LPresident, Consumer DivisionDirectSell323202639.5411,060437,3468,482,923Form
7Goldberg, Scott LPresident, Consumer DivisionDirectSell323202639.9711,060442,0788,574,717Form
8Bhojwani, Gary CChief Executive OfficerDirectSell218202643.0543,0211,852,10111,947,800Form
9Zimpfer, Matthew JGeneral CounselDirectSell218202643.0533,8001,455,14113,257,150Form
10Franzese, Yvonne KChief Human Resources OfficerDirectSell218202643.179,000388,5571,513,731Form
11Bhojwani, Gary CChief Executive OfficerDirectSell218202643.1745,3571,957,86713,836,636Form
12Zimpfer, Matthew JGeneral CounselDirectSell218202643.1723,5701,017,41313,292,285Form
13Zimpfer, Matthew JGeneral CounselDirectSell212202642.9330,9701,329,58213,220,136Form
14Bhojwani, Gary CChief Executive OfficerDirectSell102202641.9931,4301,319,6398,226,267Form
15Tarasi, Rocco F IiiChief Marketing OfficerDirectSell1215202542.609,283395,4393,149,367Form
16Franzese, Yvonne KChief Human Resources OfficerDirectSell1125202541.003,000123,000886,297Form
17Bhojwani, Gary CChief Executive OfficerDirectSell1121202539.9731,4301,256,3429,088,033Form
18Johnson, Eric RChief Investment OfficerDirectSell1113202541.2448,6652,007,01327,695,332Form
19Detoro, Karen JPresident, Worksite DivisionDirectSell815202537.859,228349,2621,584,132Form
20Linnenbringer, Jeanne LChief Operations OfficerDirectSell815202537.853,457130,8461,167,430Form
21Detoro, Karen JPresident, Worksite DivisionDirectSell815202537.986,509247,2041,940,071Form
22Linnenbringer, Jeanne LChief Operations OfficerDirectSell815202537.984,862184,6561,302,731Form
23Detoro, Karen JPresident, Worksite DivisionDirectSell815202537.969,920376,5512,186,123Form
24Linnenbringer, Jeanne LChief Operations OfficerDirectSell815202537.966,420243,7031,486,624Form
25Mead, Michael EChief Information OfficerDirectSell707202537.9712,581477,645597,161Form
26Mead, Michael EChief Information OfficerDirectSell707202538.2012,389473,2571,081,436Form

Investor Activity (13F)

Updated Aug 3, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Paradice Investment Management LLC$11.2 Mil2.1%23Hold13F
Active Manager
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Paradice Investment Management LLC$11.2 Mil2.1%23Hold13F
Core Cache Last Updated: 8/2/2026